Rachel Lenington - Nov 3, 2021 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role
Chief Operating Officer
Signature
/s/ Glenna Mileson, Attorney in Fact for Rachel Lenington
Stock symbol
ATHA
Transactions as of
Nov 3, 2021
Transactions value $
$0
Form type
4
Date filed
11/5/2021, 05:02 PM
Previous filing
Jun 14, 2021
Next filing
Jan 20, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATHA Stock Option (Right to Buy) Award $0 +150K $0.00 150K Nov 3, 2021 Common Stock 150K $15.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares subject to the option vest on June 14, 2022 and one-fourth of the shares subject to the option vest on each subsequent anniversary thereafter.